News

Rates of HIV diagnoses among adults and adolescents is higher in southern states, and organizations are looking to reverse this trend and address inequities.

Pediatric patients with COVID-19 showed higher rates of symptoms than those with influenza.

The therapy was associated with 95,000 fewer deaths through early March of 2021.

In a population-based cohort study with a mean follow-up of 3.6 years, childhood outcomes showed no statistically significant associations with any adverse health conditions.

High admission plasma ACE2 was associated with an increased maximal illness severity within 28 days.

The company recently began its phase 2/3 trial for its investigational therapy.

The therapy builds on the Prevnar 13 platform with an additional 7 serotypes.

Hesitancy is a hurdle we have been struggling with in general when it comes to vaccines, but even more so when it comes to COVID-19. Throw politicization and the nuances of EUA into this mix, and it’s not surprising we’re having to work exceedingly hard to expand vaccine uptake.

Deaths continue to plunge in Brazil as more vaccinations are administered.

With the US Centers for Disease Control and Prevention's recent change to mask guidance for vaccinated people, some confusion ensued and left state governments and businesses scrambling to react to the update.

Risk of SARS-CoV-2 infections varies among Latinx residents, with Mayan individuals experiencing the greatest risk, according to a recent study of the evaluated infections in the Fruitvale neighborhood of Oakland, Calif.

COVID-19 infections were 13.6 percentage points higher in nursing homes with 50% or more Black residents, and deaths were 3.5 percentage points higher, compared with nursing homes with no Black residents, a new study found.

Regardless of age, Alzheimer’s was seen to be a risk factor for severe disease and death.

The authorization change halves the required dose of the monoclonal antibody regimen, based on recent data.

Tembexa was developed by Chimerix and showed a statistically significant survival benefit.

Those with moderate or severe obesity had a greater risk of hospitalization at 10-month follow up.

A discussion with the CDC’s Flu Czar, Lynnette Brammer, surrounding the upcoming flu season and what we can expect due to the COVID-19 pandemic.

The government agency will be assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine.

Nanotechnology increased the efficacy of treatment for P. aeruginosa, a lung infection found in severe cases of cystic fibrosis.

Merck moved closer to offering its pneumococcal conjugate vaccine for use in pediatric populations with the recent announcement of positive topline results in 2 phase 3 pediatric clinical trials.

Metal ions in the body help to form a bridge between viral mRNA and viral proteins.

Antibodies produced by memory B cells remembering an older infection could help develop new therapies.

Participants taking methotrexate for an immune disorder did not show an increase in CD8 T cells.

A county-level study of COVID-19 vaccination rates by the US Centers for Disease Control and Prevention (CDC) reveals substantially lower rates in rural than in urban areas in the US.

Patients with moderate to severe pneumonia associated with COVID-19 and high C-reative protein levels may benefit from treatment with the monoclonal antibody tocilizumab, a follow-up study found.

A prospective study suggest co-infections and secondary infections are infrequent among COVID-19 patients, warranting the need for improved stewardship.

Mice treated with diABZI showed reduced weight loss and reduced viral load in the lungs and nostrils.

Maintaining non-pharmaceutical interventions were seen to reduce the spread of infections during computer modeling.

No evidence of an association between genetically predicted vitamin D levels and COVID-19 susceptibility were found in the study.

This is the first oral non-azole treatment for vaginal yeast infections.